Top FiveStocks - Thursday Volume Report - Superior Venture Corp, Applied DNA Sciences, Cannabis Science, Lifetech Industries, Immunovative, Inc.
LONDON, November 29, 2012 /PRNewswire/ --
Volume Trading Report: Superior Venture Corp (OTC: SVEN), Applied DNA Sciences (OTC: APDN), Cannabis Science (OTC: CBIS), Lifetech Industries (OTC: LTCH), Immunovative (OTC: IMUN).
Superior Venture Corp (OTC: SVEN) was holding steady today after two huge days of volume and the price was holding up also. At the time of writing SVEN was lower by just 4% which is tiny if you consider the upside these last few trading sessions. We will continue to track SVEN in volume and price; it still remains the most heavily traded stock on the OTCQB.
Applied DNA Sciences (OTC: APDN) was back on the volume watch list today trading higher by 4.5% on around 150k traded in the morning session Thursday on Wall Street.
Cannabis Science (OTC: CBIS) remained on the watch list today after trading 100k in the first 30 minutes of trading in the OTC markets. CBIS was also higher by 7% on the day. Lifetech Industries (OTC: LTCH) was a new name on the watch list which we have not seen before. Early on Thursday LTCH had traded 159k and was higher by 3% in the OTC markets. Immunovative (OTC: IMUN) rounds off the volume watch list today which is flat on the day with approx. 50k traded in early trading on Wall Street. If you are looking to know what's going on with these companies on the OTCQB and in addition receive weekly picks on stocks that we feature….simply sign up at our website for free. http://www.clubpennystock.com Regardless of what's going on in the mainstream we will always keep you updated and look to be value added. We hope you have enjoyed our coverage last week; we will be back to you on Thursday with our look at the OTC markets.Select the service that is right for you!
COMPARE ALL SERVICESAction Alerts PLUS
TRY IT FREEJim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
Product Features:
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
TheStreet Quant Ratings
TRY IT FREENew! $49.95/yr
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
Product Features:
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Stocks Under $10
TRY IT FREEDavid Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
Product Features:
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
- Weekly roundups
Dividend Stock Advisor
TRY IT FREEJim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
Product Features:
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
TRY IT FREEAll of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
Product Features:
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Options Profits
TRY IT FREEOur options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
Product Features:
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV
